Results 171 to 180 of about 58,889 (219)

Lunasina, un péptido alimentario biodisponible, ejerce efectos protectores frente al estrés oxidativo en células hepáticas humanas

, 2014
Samuel Fernández‐Tomé, Sonia Ramos, Isabel Cordero Herrera, Isidra Recio, Luis Goya, Blanca Hernández‐Ledesma   +5 more
openalex   +2 more sources

First-Line Prescriptions and Effectiveness of <i>Helicobacter pylori</i> Eradication Treatment in Ireland over a 10-Year Period: Data from the European Registry on <i>Helicobacter pylori</i> Management (Hp-EuReg). [PDF]

Antibiotics (Basel)
Smith SM, Nyssen OP, FitzGerald R, Butler TJ, McNamara D, Qasim A, Costigan C, Cano-Catalá A, Parra P, Moreira L, Megraud F, O'Morain C, Gisbert JP.   +12 more
europepmc   +1 more source

Metabolic Signature in Combination with Fecal Immunochemical Test as a Non-Invasive Tool for Advanced Colorectal Neoplasia Diagnosis. [PDF]

Cancers (Basel)
Albóniga OE, Cubiella J, Bujanda L, Aspichueta P, Blanco ME, Lanza B, Alonso C, Falcón-Pérez JM.   +7 more
europepmc   +1 more source

Beyond Cholesterol and Triglycerides in the Lipid Clinic: The Challenging Task of Identifying Lysosomal Acid Lipase Deficiency. [PDF]

Arq Bras Cardiol
Mizuta MH, Santos RD.
europepmc   +1 more source

In memoriam. Creu Casas (1913-2007) [PDF]

, 2007
Brugués, M. (Montserrat), Cros, Rosa M.
core  

Lesiones hepáticas diagnosticadas por tomografía multifásica de abdomen en pacientes de 30 a 80 años

Pablo José Solano-Brito, Xavier Miguel Salazar-Alvarado, Johanna Elizabeth Lozada-Arias, David Santiago Soliz-Zabala   +3 more
openalex   +2 more sources

Differential effects of tofacitinib on macrophage activation contribute to lack of response in ulcerative colitis patients. [PDF]

J Crohns Colitis
Melón-Ardanaz E, Veny M, Corraliza AM, Gudiño V, Garrido-Trigo A, Sanzo-Machuca Á, Buendia M, Esteller M, Robbins-Moreno L, Rodrigo M, Masamunt MC, Giner Á, Gallego M, Ordás I, Fernández-Clotet A, Caballol B, Corbí Á, Verstockt B, Vermeire S, Panés J, Ricart E, Salas A.   +21 more
europepmc   +1 more source

Pregnancy Outcomes After Maternal or Paternal Exposure to Tofacitinib Across Clinical Programs. [PDF]

Am J Gastroenterol
Mahadevan U, Chaparro M, Segovia M, Guo X, Kulisek N, Wu J, Vranic I, Diehl A, Kavanaugh A, Dubinsky M.   +9 more
europepmc   +1 more source

Breaking Barriers for Intensive Care Admission in Patients With Advanced HCC on Immunotherapy. [PDF]

Liver Int
Fortuny M, da Fonseca LG, Allaire M, Sánchez R, Nault JC, Iavarone M, Ridolfo S, Pascual S, Jimeno R, Calvo M, Rifà R, Sanduzzi-Zamparelli M, Jiménez-Esquivel N, Mouri S, Iñarrairaegui M, Argemi J, Hernaez T, Lorenzo-Barreto JE, Ferrer MT, Coll S, Lamarca Á, Marin JI, Reverter E, López AM, Lue A, Varela M, Matilla A, Fernández J, Reig M.   +28 more
europepmc   +1 more source

Screening for Mutations Causing ACOX2 Deficiency-associated Hypertransaminasemia in Patients with Cryptogenic Liver Injury. [PDF]

J Clin Transl Hepatol
Herraez E, Monte MJ, Alonso-Peña M, Prieto J, Bujanda L, Muñoz-Chimeno M, Avellon A, Marin JJG.   +7 more
europepmc   +1 more source